Centre for Community Medicine, All India Institute of Medical Sciences, New Delhi 110029, India.
J Trop Pediatr. 2021 Jan 29;67(1). doi: 10.1093/tropej/fmaa111.
INTRODUCTION: Globally around 47.4% of children and in India, 58% of children aged 6-59 months are anemic. Diagnosis of anemia in children using accurate technologies and providing adequate treatment is essential to reduce the burden of anemia. Point-of-care testing (POCT) devices is a potential option for estimation of hemoglobin in peripheral and field settings were the hematology analyzer and laboratory services are not available. OBJECTIVES: To access the validity of the POCTs (invasive and non-invasive devices) for estimation of hemoglobin among children aged 6-59 months compared with hematology analyzer. METHODS: The study participants were enrolled from the pediatric outpatient department in Haryana, India, from November 2019 to January 2020. Hemoglobin levels of the study participants were estimated in Sahli's hemoglobinometer and invasive digital hemoglobinometers (DHs) using capillary blood samples. Hemoglobin levels in non-invasive DH were assessed from the finger/toe of the children. Hemoglobin levels measured in POCTs were compared against the venous blood hemoglobin estimated in the hematology analyzer. RESULTS: A total of 120 children were enrolled. The mean (SD) of hemoglobin (g/dl) estimated in auto-analyzer was 9.4 (1.8), Sahli's hemoglobinometer was 9.2 (1.9), invasive DH was 9.7 (1.9), and non-invasive DH was 11.9 (1.5). Sahli's hemoglobinometer (95.5%) and invasive DH (92.2%) had high sensitivity for the diagnosis of anemia compared with non-invasive DH (24.4%). In contrast, non-invasive DH had higher specificity (96.7%) compared with invasive DH (83.3%) and Sahli's hemoglobinometer (70%). Invasive DH took the least time (2-3 min) for estimation of hemoglobin per participant, followed by Sahli's (4-5 min) and non-invasive DH (5-7 min). CONCLUSION: All three POCT devices used in this study are reasonable and feasible for estimating hemoglobin in under-5 children. Invasive DHs are potential POCT devices for diagnosis of anemia among under-5 children, while Sahli's can be considered as a possible option, where trained and skilled technicians are available. Further research and development are required in non-invasive DH to improve accuracy. Lay summaryIn India, anemia is a serious public health problem, where 58% of the children aged 6-59 months are anemic. Point-of-care testing (POCT) using digital hemoglobinometers (DHs) has been recommended as one of the key interventions by the Anemia Mukt Bharat program since 2018 in India. These POCT devices are easy to use, less invasive, can be carried to field, require minimal training and results are available immediately. Therefore this study assessed the validity of POCT devices-invasive DH, non-invasive DH and Sahli's hemoglobinometer among 6-59 months children in facility setting compared with the gold standard hematology analyzer. A total of 120 children under 6-59 months of age were enrolled from the pediatric outpatient department in Haryana, India, from November 2019 to January 2020. The (mean hemoglobin in g/dl) invasive (9.7) and non-invasive DH (11.9) overestimated hemoglobin value, while Sahli's (9.2) underestimated hemoglobin compared with hematology analyzer (9.4). Invasive DH (92.2%) and Sahli's hemoglobinometer (95.5%) reported high ability to correctly identify those with anemia compared with non-invasive DH (24.4%). In contrast, non-invasive DH (96.73%) had higher ability to correctly identify those without the anemia compared with invasive DH (83.3%) and Sahli's (70%).
简介:全球约有 47.4%的儿童和印度 58%的 6-59 月龄儿童患有贫血症。使用准确的技术诊断儿童贫血症并提供充足的治疗对于减轻贫血症的负担至关重要。即时检验(POCT)设备是在没有血液分析仪和实验室服务的基层和野外环境中估计血红蛋白的潜在选择。
目的:评估 POCT(有创和无创设备)与血液分析仪相比,在估计 6-59 月龄儿童血红蛋白值方面的准确性。
方法:本研究参与者于 2019 年 11 月至 2020 年 1 月从印度哈里亚纳邦的儿科门诊招募。使用毛细血管血样,用 Sahli 血红蛋白计和有创数字血红蛋白计(DH)评估研究参与者的血红蛋白水平。从儿童的手指/脚趾评估非侵入性 DH 的血红蛋白值。POCT 测量的血红蛋白值与血液分析仪估计的静脉血血红蛋白值进行比较。
结果:共纳入 120 名儿童。自动分析仪(g/dl)估计的平均(SD)血红蛋白值为 9.4(1.8),Sahli 血红蛋白计为 9.2(1.9),有创 DH 为 9.7(1.9),非侵入性 DH 为 11.9(1.5)。Sahli 血红蛋白计(95.5%)和有创 DH(92.2%)在诊断贫血方面具有较高的敏感性,而非侵入性 DH(24.4%)则较低。相比之下,非侵入性 DH 具有较高的特异性(96.7%),高于有创 DH(83.3%)和 Sahli 血红蛋白计(70%)。每例参与者使用有创 DH 进行血红蛋白估计所花费的时间最短(2-3 分钟),其次是 Sahli(4-5 分钟)和非侵入性 DH(5-7 分钟)。
结论:本研究中使用的三种 POCT 设备都可以合理、可行地估计 5 岁以下儿童的血红蛋白值。有创 DH 是诊断 5 岁以下儿童贫血的潜在 POCT 设备,而 Sahli 血红蛋白计可以作为一种可能的选择,因为有训练有素的技术人员。需要进一步研究和开发非侵入性 DH,以提高其准确性。
概述:在印度,贫血是一个严重的公共卫生问题,6-59 月龄的儿童中有 58%患有贫血。自 2018 年以来,印度的贫血无疟疾印度计划(Anemia Mukt Bharat program)推荐使用即时检验(POCT)使用数字血红蛋白计(DH)作为关键干预措施之一。这些 POCT 设备易于使用,创伤性较小,可以携带到野外,所需培训较少,结果可立即获得。因此,本研究在医疗机构环境中评估了 POCT 设备——有创 DH、无创 DH 和 Sahli 血红蛋白计在 6-59 月龄儿童中的准确性,与金标准血液分析仪进行比较。共招募了 120 名 6-59 月龄的儿童,来自印度哈里亚纳邦的儿科门诊,时间为 2019 年 11 月至 2020 年 1 月。有创(9.7)和非侵入性 DH(11.9)高估了血红蛋白值,而 Sahli(9.2)低估了与血液分析仪(9.4)相比的血红蛋白值。有创 DH(92.2%)和 Sahli 血红蛋白计(95.5%)报告具有较高的能力来正确识别贫血患者,而非侵入性 DH(24.4%)则较低。相比之下,非侵入性 DH(96.73%)具有更高的能力来正确识别没有贫血的患者,而有创 DH(83.3%)和 Sahli(70%)则较低。
Indian J Pathol Microbiol. 2009
J Postgrad Med. 1992